Atrial Fibrillation With Modern Cancer Treatment: More Common Than We Think

por Addison, Daniel, Quartermaine, Cooper, Brammer, Jonathan E.
Publicado 2023

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias

por Herling, Marco, Jarjour, Wael, Mishra, Anjali, Brammer, Jonathan E.
Publicado 2022

Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia

por Braunstein, Zachary, McLaughlin, Eric, Mishra, Anjali, Brammer, Jonathan E.
Publicado 2022

Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease

por Couette, Nina, Jarjour, Wael, Brammer, Jonathan E., Simon Meara, Alexa
Publicado 2022

Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas

por Braunstein, Zachary, Ruiz, Miguel, Hanel, Walter, Shindiapina, Polina, Reneau, John C., Brammer, Jonathan E.
Publicado 2022

79696 Reversible DNA Hypermethylation of the Interleukin-15 Promoter Induces IL-15 Expression, Drives the Pathogenesis of T-Cell Large Granular Lymphocytic Leukemia (T-LGLL) and Pr...

por Brammer, Jonathan E, Mishra, Anjali, Boles, Amy, Mansour, Anthony, Mathe-Allainmat, Monique, Quemener, Agnes, Porcu, Pierluigi
Publicado 2021

Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions

por Reneau, John C., Shindiapina, Polina, Braunstein, Zachary, Youssef, Youssef, Ruiz, Miguel, Farid, Saira, Hanel, Walter, Brammer, Jonathan E.
Publicado 2022

Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy

por Valdez, Benigno C., Li, Yang, Murray, David, Brammer, Jonathan E., Liu, Yan, Hosing, Chitra, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Publicado 2016

Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection

por Faisal, Muhammad Salman, Saad, Ayman, Mims, Alice, Vasu, Sumithira, Wall, Sarah A., Larkin, Karilyn, Choe, Hannah, Brammer, Jonathan E., Penza, Sam, Jaglowski, Samantha, De Lima, Marcos
Publicado 2022

Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

por Isabelle, Colleen, Johnson, William T., McConnell, Kathleen, Vogel, Ashley, Brammer, Jonathan E., Boles, Amy, Keller, Robyn, Sindaco, Paola, Nisenfeld, Liam, Uppal, Guldeep, Nikbakht, Neda, Calabretta, Bruno, Porazzi, Patrizia, Gong, Jerald, Chakravarti, Nitin, Porcu, Pierluigi, Mishra, Anjali
Publicado 2023

Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience

por Jiang, Justin, Sigmund, Audrey M., Zhao, Qiuhong, Elder, Patrick, Benson, Don M., Vasu, Sumithira, Jaglowski, Samantha, Mims, Alice, Choe, Hannah, Larkin, Karilyn, Brammer, Jonathan E., Wall, Sarah, Grieselhuber, Nicole, Saad, Ayman, Penza, Sam, Efebera, Yvonne A., Sharma, Nidhi
Publicado 2022

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

por Haverkos, Bradley, Alpdogan, Onder, Baiocchi, Robert, Brammer, Jonathan E., Feldman, Tatyana A., Capra, Marcelo, Brem, Elizabeth A., Nair, Santosh, Scheinberg, Phillip, Pereira, Juliana, Shune, Leyla, Joffe, Erel, Young, Patricia, Spruill, Susan, Katkov, Afton, McRae, Robert, Royston, Ivor, Faller, Douglas V., Rojkjaer, Lisa, Porcu, Pierluigi
Publicado 2023

Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias

por Braunstein, Zachary, McLaughlin, Eric, Ruiz, Miguel, Wei, Lai, Bumma, Naresh, Benson, Don, Devarakonda, Srinivas, Chaudhry, Maria, Khan, Abdullah, Cottini, Francesca, Hanel, Walter, Baiocchi, Robert, Chung, Catherine, Addison, Daniel, Couette, Nina, Meara, Alexa, Jarjour, Wael, Porcu, Pierluigi, Mishra, Anjali, Reneau, John C., Rosko, Ashley E., Brammer, Jonathan E.
Publicado 2022

Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation

por Sharma, Nidhi, Faisal, Muhammad Salman, Zhao, Qiuhong, Jiang, Justin, Elder, Patrick, Benson, Don M., Rosko, Ashley, Chaudhry, Maria, Bumma, Naresh, Khan, Abdullah, Devarakonda, Srinivas, Vasu, Sumithira, Jaglowski, Samantha, Mims, Alice S., Choe, Hannah, Larkin, Karilyn, Brammer, Jonathan E., Wall, Sarah, Grieselhuber, Nicole, Saad, Ayman, Penza, Sam, Sigmund, Audrey M., Efebera, Yvonne A.
Publicado 2021

Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma

por Brammer, Jonathan E, Braunstein, Zachary, Katapadi, Aashish, Porter, Kyle, Biersmith, Michael, Guha, Avirup, Vasu, Sumithira, Yildiz, Vedat O, Smith, Sakima A, Buck, Benjamin, Haddad, Devin, Gumina, Richard, William, Basem M, Penza, Sam, Saad, Ayman, Denlinger, Nathan, Vallakati, Ajay, Baliga, Ragavendra, Benza, Raymond, Binkley, Philip, Wei, Lai, Mocarski, Mason, Devine, Steven M, Jaglowski, Samantha, Addison, Daniel
Publicado 2021

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma

por Hanel, Walter, Shindiapina, Polina, Bond, David A., Sawalha, Yazeed, Epperla, Narendranath, Voorhees, Timothy, Welkie, Rina Li, Huang, Ying, Behbehani, Gregory K., Zhang, Xiaoli, McLaughlin, Eric, Chan, Wing K., Brammer, Jonathan E., Jaglowski, Samantha, Reneau, John C., Christian, Beth A., William, Basem M., Cohen, Jonathon B., Baiocchi, Robert A., Maddocks, Kami, Blum, Kristie A., Alinari, Lapo
Publicado 2023